Triclocarban enhances testosterone action: A new type of endocrine disruptor?

Endocrinology

Volumn 149, Issue 3, 2008, Pages 1173-1179

  Chen, Jiangang ^a   Ki, Chang Ahn ^a   Gee, Nancy A ^a,b   Ahmed, Mohamed I ^c   Duleba, Antoni J ^a,c   Zhao, Ling ^a   Gee, Shirley J ^a   Hammock, Bruce D ^a   Lasley, Bill L ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; ANTIINFECTIVE AGENT; ENDOCRINE DISRUPTOR; TESTOSTERONE; TRICLOCARBAN; UREA;

ARTICLE; CONTROLLED STUDY; DRUG BINDING; DRUG MECHANISM; DRUG STRUCTURE; ENDOCRINE FUNCTION; GENE AMPLIFICATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; ORGAN SIZE; PRIORITY JOURNAL;

ANIMALS; ANTI-INFECTIVE AGENTS, LOCAL; CARBANILIDES; CELL LINE; CELL PROLIFERATION; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DRUG SYNERGISM; ENDOCRINE DISRUPTORS; GENITALIA, MALE; HUMANS; MALE; ORGAN SIZE; PROSTATE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ANDROGEN; TESTOSTERONE;

EID: 40849139427     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2007-1057     Document Type: Article

References (50)

1. Buck Louis GM, Lynch CD, Cooney MA 2006 Environmental influences on female fecundity and fertility. Semin Reprod Med 24:147-155
2. Newbold RR, Padilla-Banks E, Snyder RJ, Phillips TM, Jefferson WN 2007 Developmental exposure to endocrine disruptors and the obesity epidemic. Reprod Toxicol 23:290-296
3. Sharpe RM, Irvine DS 2004 How strong is the evidence of a link between environmental chemicals and adverse effects on human reproductive health? BMJ 328:447-451
4. Fusani L, Della Seta D, Dessi-Fulgheri F, Farabollini F 2007 Altered reproductive success in rat pairs after environmental-like exposure to xenoestrogen. Proc Biol Sci 274:1631-1636
5. Hokanson R, Hanneman W, Hennessey M, Donnelly KC, McDonald T, Chowdhary R, Busbee DL 2006 DEHP, bis(2)-ethylhexyl phthalate, alters gene expression in human cells: possible correlation with initiation of fetal developmental abnormalities. Hum Exp Toxicol 25:687-695
6. Blanck HM, Marcus M, Tolbert PE, Rubin C, Henderson AK, Hertzberg VS, Zhang RH, Cameron L 2000 Age at menarche and tanner stage in girls exposed in utero and postnatally to polybrominated biphenyl. Epidemiology 11:641-647
7. Nebesio TD, Eugster EA 2007 Current concepts in normal and abnormal puberty. Curr Probl Pediatr Adolesc Health Care 37:50-72
8. Sanderson JT 2006 The steroid hormone biosynthesis pathway as a target for endocrine-disrupting chemicals. Toxicol Sci 94:3-21
9. Bretveld RW, Thomas CM, Scheepers PT, Zielhuis GA, Roeleveld N 2006 Pesticide exposure: the hormonal function of the female reproductive system disrupted? Reprod Biol Endocrinol 4:30
10. Savabieasfahani M, Kannan K, Astapova O, Evans NP, Padmanabhan V 2006 Developmental programming: differential effects of prenatal exposure to bisphenol-A or methoxychlor on reproductive function. Endocrinology 147:5956-5966
11. McLachlan JA, Simpson E, Martin M 2006 Endocrine disrupters and female reproductive health. Best Pract Res 20:63-75
12. Fenton SE 2006 Endocrine-disrupting compounds and mammary gland development: early exposure and later life consequences. Endocrinology 147:S18-S24
13. Maffini MV, Rubin BS, Sonnenschein C, Soto AM 2006 Endocrine disruptors and reproductive health: the case of bisphenol-A. Mol Cell Endocrinol 254-255:179-186
14. Rayner JL, Enoch RR, Fenton SE 2005 Adverse effects of prenatal exposure to atrazine during a critical period of mammary gland growth. Toxicol Sci 87:255-266
15. Lipworth L 1995 Epidemiology of breast cancer. Eur J Cancer Prev 4:7-30
16. Guillette Jr LJ 2006 Endocrine disrupting contaminants - beyond the dogma. Environ Health Perspect 114(Suppl 1):9-12
17. Dallinga JW, Moonen EJ, Dumoulin JC, Evers JL, Geraedts JP, Kleinjans JC 2002 Decreased human semen quality and organochlorine compounds in blood. Hum Reprod 17:1973-1979
18. Korner W, Vinggaard AM, Terouanne B, Ma R, Wieloch C, Schlumpf M, Sultan C, Soto AM 2004 Interlaboratory comparison of four in vitro assays for assessing androgenic and antiandrogenic activity of environmental chemicals. Environ Health Perspect 112:695-702
19. Sapkota A, Heidler J, Halden RU 2007 Detection of triclocarban and two cocontaminating chlorocarbanilides in U.S. aquatic environments using isotope dilution liquid chromatography tandem mass spectrometry. Environ Res 103:21-29
20. Nolen GA, Dierckman TA 1979 Reproduction and teratogenic studies of a 2:1 mixture of 3,4,4′-trichlorocarbanilide and 3-trifluoromethyl-4, 4′-dichlorocarbanilide in rats and rabbits. Toxicol Appl Pharmacol 51:417-425
21. Jansen MS, Nagel SC, Miranda PJ, Lobenhofer EK, Afshari CA, McDonnell DP 2004 Short-chain fatty acids enhance nuclear receptor activity through mitogen-activated protein kinase activation and histone deacetylase inhibition. Proc Natl Acad Sci USA 101:7199-7204
22. Morisseau C, Goodrow MH, Dowdy D, Zheng J, Greene JF, Sanborn JR, Hammock BD 1999 Potent urea and carbamate inhibitors of soluble epoxide hydrolases. Proc Natl Acad Sci USA 96:8849-8854
23. Newman JW, Denton DL, Morisseau C, Koger CS, Wheelock CE, Hinton DE, Hammock BD 2001 Evaluation of fish models of soluble epoxide hydrolase inhibition. Environ Health Perspect 109:61-66
24. Chen J, Sowers MR, Moran FM, McConnell DS, Gee NA, Greendale GA, Whitehead C, Kasim-Karakas SE, Lasley BL 2006 Circulating bioactive androgens in midlife women. J Clin Endocrinol Metab 91:4387-4394
25. Chen J, Ahn KC, Gee NA, Gee SJ, Hammock BD, Lasley BL 2007 Antiandrogenic properties of parabens and other phenolic containing small molecules in personal care products. Toxicol Appl Pharmacol 221:278-284
26. Jia XC, Oikawa M, Bo M, Tanaka T, Ny T, Boime I, Hsueh AJ 1991 Expression of human luteinizing hormone (LH) receptor: interaction with LH and chorionic gonadotropin from human but not equine, rat, and ovine species. Mol Endocrinol 5:759-768
27. Chen J, Thirkill TL, Overstreet JW, Lasley BL, Douglas GC 2003 Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on chorionic gonadotropin secretion by human trophoblasts. Reprod Toxicol 17:87-93
28. Yin D, He Y, Perera MA, Hong SS, Marhefka C, Stourman N, Kirkovsky L, Miller DD, Dalton JT 2003 Key structural features of nonsteroidal ligands for binding and activation of the androgen receptor. Mol Pharmacol 63:211-223
29. Kim J, Jia L, Stallcup MR, Coetzee GA 2005 The role of protein kinase A pathway and cAMP responsive element-binding protein in androgen receptor-mediated transcription at the prostate-specific antigen locus. J Mol Endocrinol 34:107-118
30. Gioeli D, Ficarro SB, Kwiek JJ, Aaronson D, Hancock M, Catling AD, White FM, Christian RE, Settlage RE, Shabanowitz J, Hunt DF, Weber MJ 2002 Androgen receptor phosphorylation. Regulation and identification of the phosphorylation sites. J Biol Chem 277:29304-29314
31. Sadar MD, Hussain M, Bruchovsky N 1999 Prostate cancer: molecular biology of early progression to androgen independence. Endocr Relat Cancer 6:487-502
32. Robinson GA, Sutherland EW 1971 On the relation of cyclic AMP to adrenergic receptors and sympathin. Adv Cytopharmacol 1:263-272
33. Skalhegg BS, Tasken K 1997 Specificity in the cAMP/PKA signaling pathway. differential expression, regulation, and subcellular localization of subunits of PKA. Front Biosci 2:d331-d342
34. Jia XC, Perlas E, Su JG, Moran F, Lasley BL, Ny T, Hsueh AJ 1993 Luminescence luteinizing hormone/choriogonadotropin (LH/CG) bioassay: measurement of serum bioactive LH/CG during early pregnancy in human and macaque. Biol Reprod 49:1310-1316
35. Ostrowski J, Kuhns JE, Lupisella JA, Manfredi MC, Beehler BC, Krystek Jr SR, Bi Y, Sun C, Seethala R, Golla R, Sleph PG, Fura A, An Y, Kish KF, Sack JS, Mookhtiar KA, Grover GJ, Hamann LG 2007 Pharmacological and x-ray structural characterization of a novel selective androgen receptor modulator: potent hyperanabolic stimulation of skeletal muscle with hypostimulation of prostate in rats. Endocrinology 148:4-12
36. Bisson WH, Cheltsov AV, Bruey-Sedano N, Lin B, Chen J, Goldberger N, May LT, Christopoulos A, Dalton JT, Sexton PM, Zhang XK, Abagyan R 2007 Discovery of antiandrogen activity of nonsteroidal scaffolds of marketed drugs. Proc Natl Acad Sci USA 104:11927-11932
37. Chen J, Hwang DJ, Bohl CE, Miller DD, Dalton JT 2005 A selective androgen receptor modulator for hormonal male contraception. J Pharmacol Exp Ther 312:546-553
38. Scharpf Jr LG, Hill ID, Maibach HI 1975 Percutaneous penetration and disposition of triclocarban in man: body showering. Arch Environ Health 30:7-14
39. Maibach HI, Feldman RJ, Milby TH, Serat WF 1971 Regional variation in percutaneous penetration in man. Pesticides. Arch Environ Health 23:208-211
40. Soto AM, Maffini MV, Schaeberle CM, Sonnenschein C 2006 Strengths and weaknesses of in vitro assays for estrogenic and androgenic activity. Best Pract Res 20:15-33
41. Hiles RA 1977 Metabolism and toxicity of halogenated carbanilides: absorption, distribution and excretion of radioactivity from 3,4,4′-trichloro[14C]carbanilide (TCC) and 3-trifluoromethyl-4,4′- dichloro[14C]carbanilide (TFC) in rats. Food Cosmet Toxicol 15:205-211
42. Chang CY, McDonnell DP 2005 Androgen receptor-cofactor interactions as targets for new drug discovery. Trends Pharmacol Sci 26:225-228
43. Gregory CW, Johnson Jr RT, Mohler JL, French FS, Wilson EM 2001 Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen. Cancer Res 61:2892-2898
44. Heinlein CA, Chang C 2002 Androgen receptor (AR) coregulators: an overview. Endocr Rev 23:175-200
45. Syms AJ, Norris JS, Panko WB, Smith RG 1985 Mechanism of androgen-receptor augmentation. Analysis of receptor synthesis and degradation by the density-shift technique. J Biol Chem 260:455-461
46. Wang Y, Chirgadze NY, Briggs SL, Khan S, Jensen EV, Burris TP 2006 A second binding site for hydroxytamoxifen within the coactivator-binding groove of estrogen receptor β. Proc Natl Acad Sci USA 103:9908-9911
47. Litvinov IV, Chang C, Isaacs JT 2004 Molecular characterization of the commonly used human androgen receptor expression vector, pSG5-AR. Prostate 58:319-324
48. Dai J, Shen R, Sumitomo M, Stahl R, Navarro D, Gershengorn MC, Nanus DM 2002 Synergistic activation of the androgen receptor by bombesin and low-dose androgen. Clin Cancer Res 8:2399-2405
49. Ikonen T, Palvimo JJ, Kallio PJ, Reinikainen P, Janne OA 1994 Stimulation of androgen-regulated transactivation by modulators of protein phosphorylation. Endocrinology 135:1359-1366
50. Moorman WJ, Cheever KL, Skaggs SR, Clark JC, Turner TW, Marlow KL, Schrader SM 2000 Male adolescent exposure to endocrine-disrupting pesticides: vinclozolin exposure in peripubertal rabbits. Andrologia 32:285-293